The expression of IFN-γ, IL-4, and IL-17A increased in draining lymph nodes (dLNs) of AD mice, however, these cytokines were reduced by the oral administration of GM2 (Figure 4B). The gene discussed is IFNG; the disease is Alzheimer disease.